CSIMarket



Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Net Income Growth by Quarter and Year

Merck And Co Inc 's Net Income results by quarter and year




MRK Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 3,759.00 -2,092.00 2,364.00
III Quarter September - 4,571.00 2,945.00 1,907.00
II Quarter June - 1,546.00 3,010.00 2,644.00
I Quarter March 4,313.00 3,186.00 3,219.00 2,862.00
FY   4,313.00 13,062.00 7,082.00 9,777.00



MRK Net Income first quarter 2022 Y/Y Growth Comment
Merck and Co Inc reported Net Income improvement of 35.37% year on year in the first quarter 2022, to $ 4,313.00 millions, this is lower than Merck And Co Inc 's recent average Net Income rise of 41.5%.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Income growth. While Merck And Co Inc ' s Net Income rise of 35.37% ranks overall at the positon no. 671 in the first quarter 2022.




MRK Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - 32.96 %
III Quarter September - 55.21 % 54.43 % -2.6 %
II Quarter June - -48.64 % 13.84 % 54.08 %
I Quarter March 35.37 % -1.03 % 12.47 % 286.23 %
FY   - 84.44 % -27.56 % 57.87 %

Financial Statements
Merck And Co Inc 's first quarter 2022 Net Income $ 4,313.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2021 Net Income $ 3,186.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Net Income Growth >>


MRK Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -17.76 % - 23.96 %
III Quarter September - 195.67 % -2.16 % -27.87 %
II Quarter June - -51.48 % -6.49 % -7.62 %
I Quarter March 14.74 % - 36.17 % 60.97 %
FY (Year on Year)   - 84.44 % -27.56 % 57.87 %




Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #20
Healthcare Sector #42
Overall #671

Net Income Y/Y Growth Statistics
High Average Low
797.92 % 41.5 % -89.24 %
IV. Quarter   (Sep. 30, 2010)
Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #20
Healthcare Sector #42
Overall #671
Net Income Y/Y Growth Statistics
High Average Low
797.92 % 41.5 % -89.24 %
IV. Quarter   (Sep. 30, 2010)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merck And Co Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
770.19 % 28.16 % -94.94 %
IV. Quarter  


MRK's I. Quarter Q/Q Net Income Comment
Merck and Co Inc achieved in the I. Quarter 2022 below company average Net Income rise of 14.74% quarter on quarter, to $ 4,313.00 millions.

Although the I. Quarter 2022 Net Income sequential growth was lower than the average , it has been still encouraging news, as the I. Quarter improvement, outshines the % Net Income growth in the I. Quarter a year ago

Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Income quarter on quarter growth. While Merck And Co Inc 's Net Income growth quarter on quarter, overall rank is 863.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #20
Healthcare Sector #49
Overall #863
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #20
Healthcare Sector #49
Overall #863
Net Income Q/Q Growth Statistics
High Average Low
770.19 % 28.16 % -94.94 %
IV. Quarter  


MRK's I. Quarter Q/Q Net Income Comment
Merck and Co Inc achieved in the I. Quarter 2022 below company average Net Income rise of 14.74% quarter on quarter, to $ 4,313.00 millions.

I. Quarter 2022 MRK's results appear to be paradoxical, albeit beneath the average, yet it demonstrates real recovery compare to the % in the same quarter a year ago.

Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Income quarter on quarter growth. While Merck And Co Inc 's Net Income growth quarter on quarter, overall rank is 863.


Merck And Co Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Income 12 Months Ending $ 14,189.00 $ 13,062.00 $ 7,211.00 $ 5,585.00 $ 7,049.00
Y / Y Net Income Growth (TTM) 101.29 % 84.44 % -37.5 % -46.81 % -30.44 %
Year on Year Net Income Growth Overall Ranking # 402 # 531 # 1084 # 1780 # 1064
Seqeuential Net Income Change (TTM) 8.63 % 81.14 % 29.11 % -20.77 % -0.47 %
Seq. Net Income Growth (TTM) Overall Ranking # 652 # 125 # 257 # 2142 # 1674




Cumulative Net Income growth Comment
Merck And Co Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 101.29% year on year, to $ 14,189 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Net Income growth was higher than company's average 37.38% and higher than 84.44% growth in Dec 31 2021.
But from twelve months ended Dec 31 2021 growth rate was beneth at 8.63 % from $13062 millions reported in twelve months ending a quarter Dec 31 2021.
In spite of, this was confirmation of strength, as the typical Q/Q TTM growth lays at 8%.
The growth was even more impressive from the previous reporting period exhibited at 8.63 % increase from $13062 millions in twelve months ending a quarter before.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 402, from total ranking in previous quarter at 531.

Net Income TTM Q/Q Growth Statistics
High Average Low
146.86 %
8 %
-87.73 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 28
Overall # 402

Net Income TTM Y/Y Growth Statistics
High Average Low
575.58 %
37.38 %
-92.46 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 46
S&P 500 # 652
Cumulative Net Income growth Comment
Merck And Co Inc saw improvement in Net Income growth trend, posting cumulative 12 months Net Income growth of 101.29% year on year, to $ 14,189 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Net Income growth was higher than company's average 37.38% and higher than 84.44% growth in Dec 31 2021.
But sequential growth rate was less at 8.63 % from $13062 millions recorded in the period from Dec 31 2021 to Mar 31 2021 Ben  Surname added on.
Still this was evidence of positive momentum, as the average sequential gain lays at 8%.
The momentum was even more impressive from the previous reporting period exhibited at 8.63 % rise from $13062 millions in twelve months ending a quarter before.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 402, from total ranking in previous quarter at 531.

Net Income TTM Q/Q Growth Statistics
High Average Low
146.86 %
8 %
-87.73 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 28
Overall # 402

Net Income TTM Y/Y Growth Statistics
High Average Low
575.58 %
37.38 %
-92.46 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 46
S&P 500 # 652




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
MRK's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for MRK's Competitors
Net Income Growth for Merck And Co Inc 's Suppliers
Net Income Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Net Income rise for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2022
Repligen Corp59.47%$ 59.470 millions
Conmed Corporation51.88%$ 51.876 millions
Becton Dickinson And Company51.33%$ 51.333 millions
Iqvia Holdings Inc 49.77%$ 49.770 millions
Charles River Laboratories International inc 48.94%$ 48.942 millions
Co diagnostics Inc.48.31%$ 48.305 millions
Phibro Animal Health Corp45.46%$ 45.457 millions
Abcellera Biologics Inc 43.81%$ 43.808 millions
Medpace Holdings Inc 41.58%$ 41.576 millions
Eli Lilly And Company40.40%$ 40.404 millions
Abbott Laboratories36.48%$ 36.475 millions
Merck and Co Inc 35.37%$ 35.374 millions
Bio techne Corp32.47%$ 32.470 millions
The Pennant Group Inc 26.83%$ 26.835 millions
Abbvie Inc 26.39%$ 26.385 millions
Tenet Healthcare Corp26.13%$ 26.126 millions
Glucotrack Inc.20.91%$ 20.907 millions
Syneos Health Inc 19.24%$ 19.244 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FACA's Profile

Stock Price

FACA's Financials

Business Description

Fundamentals

Charts & Quotes

FACA's News

Suppliers

FACA's Competitors

Customers & Markets

Economic Indicators

FACA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071